PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-47.69%
Negative revenue growth while ECL.AX stands at 10799.78%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.48%
Gross profit growth under 50% of ECL.AX's 10799.78%. Michael Burry would be concerned about a severe competitive disadvantage.
-48.14%
Negative EBIT growth while ECL.AX is at 32358.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-48.14%
Negative operating income growth while ECL.AX is at 32358.17%. Joel Greenblatt would press for urgent turnaround measures.
-64.13%
Negative net income growth while ECL.AX stands at 849.04%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-62.96%
Negative EPS growth while ECL.AX is at 847.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-62.96%
Negative diluted EPS growth while ECL.AX is at 852.96%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.58%
Share reduction while ECL.AX is at 0.72%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.64%
Slight or no buyback while ECL.AX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-163.45%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-180.97%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
482.38%
10Y revenue/share CAGR above 1.5x ECL.AX's 38.08%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
546.35%
5Y revenue/share CAGR above 1.5x ECL.AX's 65.98%. David Dodd would look for consistent product or market expansions fueling outperformance.
314.68%
3Y revenue/share CAGR above 1.5x ECL.AX's 19.44%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-2943.31%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-6929.20%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-250.99%
Negative 3Y OCF/share CAGR while ECL.AX stands at 20088.62%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
2072.00%
Below 50% of ECL.AX's 4670.29%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1593.94%
5Y net income/share CAGR at 50-75% of ECL.AX's 2138.76%. Martin Whitman might see a shortfall in operational efficiency or brand power.
469.94%
Below 50% of ECL.AX's 1363.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
86332.39%
10Y equity/share CAGR above 1.5x ECL.AX's 143.26%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
238.84%
5Y equity/share CAGR above 1.5x ECL.AX's 141.16%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
74.60%
3Y equity/share CAGR at 50-75% of ECL.AX's 116.14%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.89%
Firm’s AR is declining while ECL.AX shows 220.93%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
96.60%
We show growth while ECL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
19.14%
Asset growth well under 50% of ECL.AX's 40.23%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
20.81%
Under 50% of ECL.AX's 60.25%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
111.67%
Debt growth of 111.67% while ECL.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
94.56%
We expand SG&A while ECL.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.